85-2707-41 Abiraterone 1g CAS No:154229-19-3 258687
特徴
- Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
- Alternate Name:(3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; CB 7598
- Molecular Formula:C₂₄H₃₁NO
- Molecular Weight349.51
- Appearance:Supplied as a white to off-white powder.
- Purity (HPLC):≥98%
- Storage and Stability:May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
- Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
- Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
仕様
- Size:1g
- Grade:Highly Purified
- Purity:≥98% (HPLC)
- Form:Supplied as a white to off-white powder.
- Molecular Formula:C₂₄H₃₁NO
- Molecular Weight Non Ab:349.51
- EU Commodity Code:38220090
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- CAS No :154229-19-3
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-2707-40
Abiraterone 500mg
|
|
|
85-2707-37
Abiraterone 25mg
|
|
|
85-2707-41
Abiraterone 1g
|
|
|
85-2707-38
Abiraterone 100mg
|
|
|
85-2707-39
Abiraterone 250mg
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





